!!Andrea Varrone - Curriculum Vitae
\\
__COURSES AND DEGREES__
\\
*1994 Graduated “cum Laude “from the School of Medicine, University “Federico II” of Naples, Italy\\
*1998 Board in Nuclear Medicine, University “Federico II” of Naples, Italy\\
*2008 Approval from Socialstyrelsen of Medical License and Specialty in Nuclear Medicine
\\
__DOCTORAL DEGREE:__ 2003, Ph.D. in “Functional Radioisotopic Imaging”, Title of the thesis: SPECT imaging of the dopamine transporter in Parkinson´s disease and multiple system atrophy, University “La Sapienza” of Rome, Italy, Prof. Francesco Scopinaro.\\2012-03-07, Docent i Nuklearmedicin\\
\\
__POSITIONS__
\\
*2023-09-01-present: Professor of Molecular PET, Karolinska Institutet, Department of Clinical Neuroscience, Centre for Psychiatry Research, 85% Head of Division of Imaging Core Facilities, Karolinska Institutet, Department of Clinical Neuroscience\\
*Scientific Director of Core Facilities Brain Molecular Imaging Centre (BMIC), Radiopharmacy Core Facility (RCF) and Autoradiography (ARG) RALF (Radiologisk Ledningsfunktion), Stockholm Health Care Services, 15%\\
*2020-2023: Lead Specialist and Director, Clinical Biomarkers Department, H. Lundbeck A/S, Copenhagen, Denmark\\
*2011-06-01-2013-05-31: Senior Researcher, Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden. \\
*2007-06-01-2011-05-31: Forskarassistent, Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet, Stockholm Brain Institute, Stockholm, Sweden.\\
*Dec 2001 - June 2007: Research Scientist, Biostructure and Bioimaging Institute, National Research Council, Naples, Italy.\\
*Dec 2000 - Dec 2001: Research collaborator with National Research Council, “Centro C.N.R. per la Medicina Nucleare” of Naples, Italy.\\
*Aug 1997- Aug 2000: Post-doctoral Associate Departments of Psychiatry and Diagnostic Radiology, Yale University School of Medicine, New Haven, and VA Connecticut, West Haven, CT, USA.\\
\\
Nuclear medicine specialist with responsibility for the radiation safety (RALF – Radiologisk Ledningsfunktion) of patients and research participants examined in brain PET studies conducted in the Core Facility Brain Molecular Imaging Centre (BMIC), within the Centre for Psychiatry Research at the Department of Clinical Neuroscience (KI) and Stockholm Health Care Services (SLSO). \\
\\
__2006-present:__ Collaborator, principal investigator and sub-investigator in Phase 0 and Phase 1 clinical trials sponsored by pharmaceutical companies.\\
\\
Member of the Neuroimaging Committee of the European Association of Nuclear Medicine. First assignment 2003-2009, second assignment 2019-2020, third assignment 2025-.\\
\\
__Clinical use of results__ \\
\\
AV has worked intensively in the last 10 years on the development and validation of the PET radioligand [[18F]FE-PE2I as diagnostic tool for the assessment of patients with Parkinson´s disease. The tracer is now one of the radioligands that have been set-up at the radiopharmacy of the Nya Karolinska Solna for clinical use in patients with Parkinsonism.\\ \\[{ALLOW view All}][{ALLOW edit avarrone}][{ALLOW upload avarrone}][{ALLOW comment All}]